We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

EUROIMMUN AG

EUROIMMUN is an international provider of medical laboratory products for autoimmune, infection, allergy and molecula... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Testing Methods Compared for Myositis Specific Autoantibodies

By LabMedica International staff writers
Posted on 28 Jun 2016
Print article
Image: A histopathology of polymyositis showing endomysial mononuclear inflammatory infiltrate and muscle fiber necrosis (Photo courtesy of Ramesh Pappu, MD, DPH).
Image: A histopathology of polymyositis showing endomysial mononuclear inflammatory infiltrate and muscle fiber necrosis (Photo courtesy of Ramesh Pappu, MD, DPH).
The performance of a line blot assay for the identification of autoantibodies in sera of patients affected by myositis has been compared with immunoprecipitation (IP) as gold standard.

Myositis refers to any condition causing inflammation in muscles and weakness, swelling, and pain are the most common myositis symptoms. Myositis causes include infection, injury, autoimmune conditions, and drug side effects and treatment of myositis varies according to the cause.

Immunologists at the University of Brescia (Italy) and their colleagues tested sera of 66 sera of patients with myositis, 23 polymyositis, eight anti-synthetase syndromes, 29 dermatomyositis and six overlap syndromes, by a commercial line blot (LB, Euroimmun, Lubeck, Germany); 57 sera were analyzed also by IP of K562 cell extract radiolabeled with 35S-methionine. Inter-rater agreement was calculated with Cohen's κ coefficient.

The scientists found that myositis-specific antibodies (MSA) could be detected in 36/57 (63%) of sera by IP and in 39/66 (59%) of sera by LB. The most frequent MSA found by LB were anti- histidyl tRNA synthetase (Jo1) and anti-Mi2 nuclear antigen found in 15% (10/66) of sera, followed by anti- nuclear matrix protein 2 (NXP2) and anti- signal recognition particle (SRP) detected in 10.6% (7/66) of sera. Anti- transcriptional intermediary factor 1 gamma (TIF1γ) and anti- Melanoma Differentiation-Associated protein 5 (MDA5) were found in six (9%) and five sera (7.6%), respectively.

The authors concluded that the use of the LB assay allowed the detection of new MSA, such as anti-MDA5, anti-MJ and anti-TIF1gamma antibodies, previously not found with routine methods. However, the high prevalence of multiple positives and the high discordant rate of anti-Jo1 antibodies could create some misinterpretation of the results from the clinical point of view. The study was published in the June 2016 issue of the Journal of Immunological Methods.

Related Links:
University of Brescia
Euroimmun
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.